Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 194

Results For "improve"

2631 News Found

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
News | June 16, 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development


QIAGEN selects TCS for cloud transformation strategy
Digitisation | June 16, 2022

QIAGEN selects TCS for cloud transformation strategy

QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth


Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
Public Health | June 15, 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa

This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.


Piramal Pharma expands API capabilities at Digwal
News | June 15, 2022

Piramal Pharma expands API capabilities at Digwal

Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies


InfuSystem and Ventis ink sales agreement for pain management
News | June 15, 2022

InfuSystem and Ventis ink sales agreement for pain management

The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management


Philips announces positive research results from its TOBA II BTK clinical trial
Clinical Trials | June 14, 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’
Healthcare | June 12, 2022

Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’

India’s first oncology laboratory for comprehensive Cancer Diagnostic services


Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis
Clinical Trials | June 12, 2022

Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis

Amarex Clinical Research guides its client to phase II of FDA trials


Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany
News | June 12, 2022

Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany

Cantourage introduces second Clever Leaves medical cannabis product to the German market